Muscle pain associated with daptomycin

The Annals of Pharmacotherapy
Shailaja R VeligandlaPhilip W Smith

Abstract

To report a case of muscle pain without pronounced creatine kinase (CK) elevation in a patient receiving daptomycin. A 26-year-old African American woman had antibiotic intolerance to vancomycin and quinupristin/dalfopristin. She presented with methicillin-resistant Staphylococcus aureus endocarditis that was treated with intravenous daptomycin 6 mg/kg daily for 14 days. The patient developed muscle aches and pains with only a minor elevation (492 U/L) of CK; both resolved after daptomycin was discontinued. Daptomycin is a newly approved lipopeptide antibiotic derived from Streptomyces roseosporus with rapid bactericidal activity. Daptomycin has excellent coverage against gram-positive bacteria. The adverse effect profile has included rare reports of myopathy and elevated CK levels. Daptomycin is a promising agent with many potential applications. Once-daily dosing has diminished the preclinical incidence of myopathy. The current package labeling recommends discontinuation of daptomycin with significant myopathy symptoms in association with a CK elevation >1000 U/L or in patients without muscle pain and a CK >10 times normal. An objective causality assessment revealed that the myopathy was possibly related to daptomycin. Clinic...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Mar 6, 1999·Annals of Internal Medicine·R C Moellering
Jul 1, 1999·Clinics in Chest Medicine·S K Fridkin, R P Gaynes
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·F B OlesonF P Tally
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Peter C FuchsSteven D Brown

❮ Previous
Next ❯

Citations

Oct 15, 2014·Current Opinion in Infectious Diseases·Pranita D Tamma, Alice J Hsu
Mar 25, 2008·Therapeutics and Clinical Risk Management·D Matthew ShoemakerWilliam E Roland
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary E Stein
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stella PapadopoulosBrian S Murphy
Sep 14, 2007·Scandinavian Journal of Infectious Diseases·Cheryl A Burns
Feb 10, 2012·Revista clínica española·D Abad-PérezI García-Polo
Jan 31, 2012·Medicina clínica·Carlos FerreraCarmen Olmos
Dec 25, 2007·International Journal of Antimicrobial Agents·Nesrene S OmarJim Gray
Nov 25, 2005·Pharmacotherapy·Cristina A Santos, Joseph I Boullata
Jun 13, 2015·Indian Journal of Pharmacology·Neel Jayesh Shah
Oct 18, 2007·Pharmacology·Robert SauermannChristian Joukhadar
Apr 3, 2008·The Annals of Pharmacotherapy·George AbrahamLinda M Spooner
May 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christopher A SchrieverLarry H Danziger
Mar 4, 2005·The Journal of Antimicrobial Chemotherapy·Kelly EchevarriaJames S Lewis
Jan 18, 2006·The Journal of Antimicrobial Chemotherapy·Amir KazoryI David Weiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.